Coronavirus vaccine developers are apparently putting that theory to rest according to a report by Bloomberg. The companies, which reportedly include Pfizer, Moderna, Johnson & Johnson, GlaxoSmithKline, Sanofi, and potentially others, plan to issue a statement pledging not to send any coronavirus vaccine to the FDA unless it has extensive safety and efficacy data. The statement could come as early as next week according to Bloomberg's sources.
Pfizer and its partner BioNTech have said they expect to have enough early-stage data from their phase 3 study in October to submit an application to the FDA. Last week, the Financial Times reported that AstraZeneca might have its coronavirus vaccine authorized by the FDA before the election, although the British drugmaker said it hadn't discussed the possibility with the agency.
snip….
The FDA has scheduled a meeting of outside experts on October 22 to discuss coronavirus vaccine development, although it isn't clear at this point which specific vaccines might be discussed.
www.fool.com/...